AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
“I don’t want to be the richest man in the cemetery” — Morris Kahn on giving it all away at 95
2
Layoffs loom as Intel’s new CEO moves to fix slow decision-making and chip production
3
From startup exits to psychedelic therapy: Eyal Gura’s new mission
4
Romance, lies, and ChatGPT: The scandal shaking Tel Aviv’s startup scene
5
"Trump’s behavior is destructive. Americans elected an infantile narcissist, and he is causing enormous harm"
More news

Entera

4 stories about Entera
נאסדק

Drug Developer Entera Bio Down on Nasdaq Following Amgen Deal

12.12.18|Lilach Baumer
The deal, announced Tuesday, could see Entera receive up to $270 million in aggregate payments
תרופות זירת הבריאות

Entera Bio Gives Nasdaq IPO Another Shot

21.05.18|Dror Reich
This is the fourth time since 2014 that the Jerusalem-based biomed company files for an initial public offering on Nasdaq
תל אביב קו רקיע Tel Aviv Skyline

CTech’s Daily Israeli Tech News Roundup

08.01.18|CTech
Israeli investment house to open crypto unit. A closer look at the first company funded by Koch’s new venture capital firm. Intuition Robotics expands funding round, nabbing Samsung as an investor.
נאסד"ק וול סטריט

For the Fourth Time, Entera Bio Tries for Nasdaq IPO

08.01.18|Dror Reich
The Jerusalem-based biomed company plans to raise $55 million, with Oppenheimer & Co. as the sole underwriter